Eckert & Ziegler Hosts Successful Boston Radionuclide Theranostics Forum

On May 29, 2025, Eckert & Ziegler held the 3rd annual Boston Radionuclide Theranostics Forum, signifying its prominence in the radiopharmaceutical sector. The event, which attracted about 100 participants, delved into the evolving role of radionuclide theranostics in precision oncology. The forum featured panel discussions and presentations on advancements in radiopharmaceuticals and their supply chain, as well as clinical development challenges. Key industry leaders and experts shared insights on the potential of this technology. The event was fully attended, highlighting the industry's strong interest in radiotheranostics.

Dr. Harald Hasselmann, CEO of Eckert & Ziegler SE, emphasized the forum's importance in accelerating progress and enhancing patient access to innovative therapies. The event was organized with the support of sponsors like Solomon Partners and Morrison Foerster, alongside the German American Business Council of Boston. The next edition is scheduled for May 28, 2026, as the company continues to foster global collaboration in the field.